Scott B. Tran

发表

Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans

V. Arora, A. Allentoff, J. Gan, 2011, Drug Metabolism and Disposition.

Metabolism and Disposition of [ 14 C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans □ S

V. Arora, A. Allentoff, J. Gan, 2011 .

Disposition of [1′-14C]Stavudine after Oral Administration to Humans

V. Roongta, B. Warrack, S. Kaul, 2010, Drug Metabolism and Disposition.

Design and synthesis of poly ADP-ribose polymerase-1 inhibitors. 2. Biological evaluation of aza-5[H]-phenanthridin-6-ones as potent, aqueous-soluble compounds for the treatment of ischemic injuries.

Jie Zhang, V. Kalish, Lisa T. Morgan, 2003, Journal of medicinal chemistry.

Synthesis of lead LFA-1 antagonist [14C]spyrocyclic hydantoin

L. Leith, M. Ogan, B. Maxwell, 2009 .

ADMINISTRATION TO HUMANS

V. Roongta, B. Warrack, S. Kaul, 2010 .

Synthesis of [13C4]Baraclude® (entecavir)

Scott B. Tran, I. Ekhato, J. K. Rinehart, 2009 .

Disposition of [1 (cid:1) - 14 C]Stavudine after Oral Administration to Humans

V. Roongta, B. Warrack, S. Kaul, 2010 .

The synthesis of [1-14 C]2-(1H-tetrazol-5-yl)acetic acid.

B. Maxwell, Scott B. Tran, 2017, Journal of labelled compounds & radiopharmaceuticals.

The syntheses of [(14) C]BMS-823778 for use in a human ADME clinical study and of [(13) CD3 (13) CD2 ]BMT-094817, a stable-isotope labeled standard of a newly detected human metabolite.

B. Maxwell, S. Bonacorsi, M. Lago, 2016, Journal of labelled compounds & radiopharmaceuticals.

A novel synthesis of [2-14C]2,5-dichloropyrimidine

B. Maxwell, S. Bonacorsi, Hongui Wu, 2011 .